Biotech Stock Picking - 2003 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking - 2003

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EVENT HORIZON III who wrote (116)	1/12/2003 2:19:39 PM
From: Icebrg	of 383

>>Curious any biotechs come to mind that are advancing any autism products through R&D or Phase testing?>> One such company is Cortex. It's a microbio. Market cap. is only 12 mUSD. (It's on Dr Tracy's B-list, though). And this is not completely off-topic here, as I have got some in my portfolio. Erik IRVINE, Calif. (April 30, 2002) — Cortex Pharmaceuticals, Inc. (AMEX: COR), today announced that the company is collaborating with several research organizations to carry out a phase II clinical study to evaluate one of the company’s AMPAKINE® compounds as a potential treatment for fragile X syndrome and autism. Organizations participating in the study include the FRAXA Research Foundation, Rush-Presbyterian-St. Luke’s Medical Center in Chicago, and the Child and Adolescent Psychiatry Department at the University of Chicago.... cortexpharm.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next